Koyro Tobias F, Kraus Emma, Lunemann Sebastian, Hölzemer Angelique, Wulf Sonia, Jung Johannes, Fittje Pia, Henseling Florian, Körner Christian, Huber Tobias B, Grundhoff Adam, Wiech Thorsten, Panzer Ulf, Fischer Nicole, Altfeld Marcus
III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; German Center for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany; Research Department Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
German Center for Infection Research (DZIF), Partner site Hamburg-Lübeck-Borstel-Riems, Hamburg, Germany; Research Group Virus Genomics, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kidney Int. 2021 May;99(5):1140-1148. doi: 10.1016/j.kint.2020.12.014. Epub 2020 Dec 23.
BK polyomavirus-associated nephropathy is a common complication after kidney transplantation leading to reduced graft function or loss. The molecular pathogenesis of BK polyomavirus-induced nephropathy is not well understood. A recent study had described a protective effect of the activating natural killer cell receptor KIR3DS1 in BK polyomavirus-associated nephropathy, suggesting a role of NK cells in modulating disease progression. Using an in vitro cell culture model of human BK polyomavirus infection and kidney biopsy samples from patients with BK polyomavirus-associated nephropathy, we observed significantly increased surface expression of the ligand for KIR3DS1, HLA-F, on BK polyomavirus-infected kidney tubular cells. Upregulation of HLA-F expression resulted in significantly increased binding of KIR3DS1 to BK polyomavirus-infected cells and activation of primary KIR3DS-positive natural killer cells. Thus, our data provide a mechanism by which KIR3DS-positive natural killer cells can control BK polyomavirus infection of the kidney, and rationale for exploring HLA-F/KIR3DS1 interactions for immunotherapeutic approaches in BK polyomavirus-associated nephropathy.
BK 多瘤病毒相关性肾病是肾移植后常见的并发症,可导致移植肾功能减退或丧失。BK 多瘤病毒所致肾病的分子发病机制尚不清楚。最近一项研究描述了激活型自然杀伤细胞受体 KIR3DS1 在 BK 多瘤病毒相关性肾病中的保护作用,提示自然杀伤细胞在调节疾病进展中发挥作用。利用人 BK 多瘤病毒感染的体外细胞培养模型和 BK 多瘤病毒相关性肾病患者的肾活检样本,我们观察到 BK 多瘤病毒感染的肾小管细胞上 KIR3DS1 的配体 HLA-F 的表面表达显著增加。HLA-F 表达上调导致 KIR3DS1 与 BK 多瘤病毒感染细胞的结合显著增加,并激活原发性 KIR3DS 阳性自然杀伤细胞。因此,我们的数据提供了一种机制,通过该机制 KIR3DS 阳性自然杀伤细胞可以控制 BK 多瘤病毒对肾脏的感染,也为探索 HLA-F/KIR3DS1 相互作用在 BK 多瘤病毒相关性肾病免疫治疗方法中的应用提供了理论依据。